Duration of effects of phenylbutazone on serum total thyroxine and free thyroxine concentrations in horses

The objectives of this study were to determine if phenylbutazone decreased serum thyroxine (TT4) and free thyroxine (FT4) concentrations using radioimmunoassay and equilibrium dialysis techniques in horses, and, if so, an additional objective was to determine the duration of this decreased concentra...

Full description

Saved in:
Bibliographic Details
Published in:Journal of veterinary internal medicine 1997-11, Vol.11 (6), p.371-374
Main Authors: Ramirez, S, Wolfsheimer, K.J, Moore, R.M, Mora, F, Bueno, A.C, Mirza, T
Format: Article
Language:English
Subjects:
Animals
BLOOD SERUM
CABALLOS
CHEVAL
Dialysis
DRUGS
EFECTOS SECUNDARIOS
EFFET SECONDAIRE
Female
FENILBUTAZONA
HORSES
Horses - blood
Male
MEDICAMENT
MEDICAMENTOS
NONTARGET EFFECTS
PHENYLBUTAZONE
Phenylbutazone - pharmacology
Radioimmunoassay
Reference Values
SERUM SANGUIN
SIDE EFFECTS
SUERO SANGUINEO
THYROXINE
Thyroxine - blood
Time Factors
TIROXINA
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The objectives of this study were to determine if phenylbutazone decreased serum thyroxine (TT4) and free thyroxine (FT4) concentrations using radioimmunoassay and equilibrium dialysis techniques in horses, and, if so, an additional objective was to determine the duration of this decreased concentration once phenylbutazone administration was discontinued. Serum TT4 and FT4 concentrations were determined before and after administration of 4.4 mg/kg of phenylbutazone IV bid for 5 days. Treatment with phenylbutazone caused a significant decrease in TT4 and FT4 concentrations (P < .05). Serum TT4 concentration significantly decreased after day 4 of treatment and remained significantly below baseline value for 10 days after discontinuing phenylbutazone administration; it returned to a value not different from the baseline value by the 11th day. Serum FT4 concentration significantly decreased after day 4 of treatment and remained significantly below the baseline value for only 1 day after phenylbutazone administration was discontinued; it returned to a value not different from the baseline value by the 3rd day after discontinuation of phenylbutazone. These results indicate that serum TT4 and FT4 should not be used to evaluate thyroid function in horses receiving phenylbutazone. In addition, results should be interpreted cautiously when phenylbutazone has been administered within 2 days (for FT4) or within 10 days (for TT4) of sample collection.
ISSN:0891-6640
1939-1676
DOI:10.1111/j.1939-1676.1997.tb00483.x